PDXK and acute myeloid leukemia: A CRISPR/Cas9 functional genomic screen targeting metabolic enzymes found that pyridoxal kinase (PDXK, an enzyme that produces pyridoxal phosphate (PLP) from vitamin B6) acts an acute myeloid leukemia (AML)-selective dependency (145).